Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does ovarian follicle depletion cause low estradiol and progesterone with high FSH and LH in menopause?

Yes — menopausal follicle exhaustion leads to persistently low estradiol and progesterone accompanied by markedly elevated FSH and LH.

SupportedJune 19, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

In menopause, ovarian follicle depletion causes persistently low estradiol and progesterone with higher follicle-stimulating hormone and luteinizing hormone.

laying out figure…
All 8 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes menopause as a consequence of ovarian reserve exhaustion, which reduces ovarian steroid production and removes negative feedback on the pituitary. Mechanistically, loss of follicles and granulosa cell function lowers estradiol and inhibin, driving a compensatory rise in pituitary gonadotropins (FSH and LH).

Verified conclusion

The transition into menopause is characterized by a fundamental shift in the hypothalamic-pituitary-ovarian (HPO) axis, driven primarily by the exhaustion of the ovarian reserve. This process results in a predictable hormonal profile defined by low circulating steroids and significantly elevated gonadotropins.

Clinical effectiveness and hormone profiles

The depletion of the primordial follicle pool is the established physiological cause of the hormonal changes that define menopause. Clinical longitudinal data, such as the Study of Women's Health Across the Nation (SWAN), show that as follicles are lost, the ovaries' capacity for steroidogenesis declines sharply.

  • Estradiol and Progesterone: Postmenopausal women typically exhibit serum estradiol levels below 30 pg/mL. The absence of ovulation means the corpus luteum does not form, leading to a persistent state of low progesterone.
  • Gonadotropins (FSH and LH): In response to low ovarian output, the pituitary gland increases secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH levels typically rise above 30–40 mIU/mL, and often reach ranges of 30–120 mIU/mL, while LH also increases significantly (20–70 mIU/mL).

Mechanistic explanations

The endocrine hallmark of menopause is "hypergonadotropic hypogonadism," which occurs through a disruption of the negative feedback loop.

  • Feedback Loss: Under reproductive conditions, maturing follicles produce estradiol and inhibin B. These hormones provide negative feedback to the hypothalamus and pituitary, suppressing GnRH and FSH secretion.
  • The FSH Rise: As the follicle count drops, inhibin B levels fall first, removing the primary "brake" on FSH. This is why FSH often rises before a significant drop in estradiol is observed in early perimenopause.
  • Cellular Depletion: The loss of granulosa cells within the follicles results in the downregulation of key enzymes like aromatase (CYP19A1). Without these cells and enzymes, the ovary cannot convert cholesterol into estradiol, even when stimulated by high levels of FSH.

Bottom line

The claim is fully supported by established medical science. The depletion of ovarian follicles removes the negative feedback provided by estradiol and inhibin B, resulting in the characteristic menopausal profile of persistently low estradiol and progesterone accompanied by high levels of FSH and LH.

References

  1. Reproductive hormones and the menopause transition. — pmc.ncbi.nlm.nih.gov ↗
  2. Endocrinology of the Menopause. — pmc.ncbi.nlm.nih.gov ↗
  3. A Review on Electrochemical and Optical Nanobiosensor for the Detection of Progesterone and Estradiol — chemistry-europe.onlinelibrary.wiley.com ↗
  4. Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model — nature.com ↗
  5. Determination of the roles of GREM1 gene in granulosa cell proliferation and steroidogenesis of hen ovarian prehierarchical follicles. — linkinghub.elsevier.com ↗
  6. Postmenopausal Hyperandrogenism — pmc.ncbi.nlm.nih.gov ↗
  7. Diagnostic challenges in suspected premature ovarian insufficiency — pmc.ncbi.nlm.nih.gov ↗
  8. [How to diagnose menopause? Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines]. — linkinghub.elsevier.com ↗
  9. Hormonal Changes During Menopause and Their Impact on Bone Health: Insights from Orthopedic and Reproductive Medicine — cureus.com ↗
  10. Menoprogen, a TCM Herbal Formula for Menopause, Increases Endogenous E2 in an Aged Rat Model of Menopause by Reducing Ovarian Granulosa Cell Apoptosis — hindawi.com ↗
  11. Hormone changes associated with the menopausal transition. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→